ArticleInternational journal of hematology2022

Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3-ITD-mutated acute myeloid leukemia.

Semra Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.